First Trust Advisors’s Kymera Therapeutics KYMR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-93,795
| Closed | -$2.57M | – | 2657 |
|
|
2025
Q1 | $2.57M | Sell |
93,795
-82,425
| -47% | -$2.26M | ﹤0.01% | 1670 |
|
|
2024
Q4 | $7.09M | Buy |
176,220
+53,175
| +43% | +$2.14M | 0.01% | 1191 |
|
|
2024
Q3 | $5.82M | Sell |
123,045
-15,591
| -11% | -$738K | 0.01% | 1254 |
|
|
2024
Q2 | $4.14M | Buy |
138,636
+70,894
| +105% | +$2.12M | ﹤0.01% | 1358 |
|
|
2024
Q1 | $2.72M | Buy |
+67,742
| New | +$2.72M | ﹤0.01% | 1598 |
|
|
2023
Q3 | – | Sell |
-26,591
| Closed | -$611K | – | 2441 |
|
|
2023
Q2 | $611K | Buy |
+26,591
| New | +$611K | ﹤0.01% | 2096 |
|
|
2022
Q3 | – | Sell |
-30,055
| Closed | -$592K | – | 2548 |
|
|
2022
Q2 | $592K | Sell |
30,055
-24,654
| -45% | -$486K | ﹤0.01% | 2152 |
|
|
2022
Q1 | $2.32M | Sell |
54,709
-38,887
| -42% | -$1.65M | ﹤0.01% | 1727 |
|
|
2021
Q4 | $5.94M | Buy |
+93,596
| New | +$5.94M | 0.01% | 1281 |
|